Detalles de la búsqueda
1.
Use of surfactant-based amorphous solid dispersions for BDDCS class II drugs to enhance oral bioavailability: A case report of resveratrol.
Int J Pharm
; 641: 123059, 2023 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37196879
2.
Co-amorphous systems using epigallocatechin-3-gallate as a co-former: Stability, in vitro dissolution, in vivo bioavailability and underlying molecular mechanisms.
Eur J Pharm Biopharm
; 178: 82-93, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35932965
3.
Excipient-free nanodispersions dominated by amphiphilic glycosides for bioavailability enhancement of hydrophobic aglycones, a case of glycyrrhetinic acid with diammonium glycyrrhizinate.
Int J Pharm
; 620: 121770, 2022 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483618
Resultados
1 -
3
de 3
1
Próxima >
>>